BackTable / MSK / Podcast / Transcript #37
Podcast Transcript: Cryoneurolysis Pearls & Pitfalls
with Dr. Alexa Levey
In this episode of the BackTable Podcast, host Dr. Jacob Fleming and Dr. Alexa Levey have an in-depth discussion about the current uses and potential future applications of cryoneurolysis in interventional radiology. Dr. Levey is an interventional radiologist at the Memorial Hermann Health System in Houston, TX. You can read the full transcript below and listen to this episode here on BackTable.com.
Table of Contents
(1) Building Cryoablation Practices: Challenges & Strategies
(2) Cryoneurolysis Versus Radiofrequency Ablation in Pain Management
(3) Patient Selection & Communication in Cryoablation
(4) Stellate Ganglion: Functions, Treatments, & Innovations in Pain Management
(5) Mitigating Risks in Stellate Ganglion Interventions
(6) Cryoprobe Selection for Effective Stellate Ganglion Procedures
(7) Pearls & Pitfalls in Stellate Ganglion Neurolysis
(8) Future Directions for Cryoneurolysis: From Innovation to Mainstream Adoption
This podcast is supported by:
Listen While You Read
Follow:
Subscribe:
Sign Up:
[Dr. Jacob Fleming]
Hello, everyone, and welcome to The Backtable MSK Podcast: your source for all things musculoskeletal. You can find all previous episodes of our show on Spotify, Apple Podcasts, and on backtable.com. This is your host, Jacob Fleming. Today, I have a very special guest, Dr. Alexa Levey.
[Dr. Alexa Levey]
Chevy to the Levey, that's completely right.
[Dr. Jacob Fleming]
Chevy to the Levey. Joining us from Houston. Another Texan friend, always welcome on the show. Dr. Levey, thanks for your time. Welcome to the show.
[Dr. Alexa Levey]
Absolute pleasure to be here. Pleasure to be here with. I had no idea you were a trainee. How you were doing this and training and having a child, my hat is off to you.
[Dr. Jacob Fleming]
Thank you. Sometimes I'm not sure. Just as with so many things in life, you just do it and it ends up being a lot of fun. I think our discussion today is going to be a lot of fun talking about cryoneurolysis, a really hot topic that's been blowing up. You have really caught a lot of attention with really cool cases you've been sharing on Twitter. Now, this is something I was talking about at a conference with some other people recently about these cool cases that you're showing.
We really want to get a little bit into the nitty gritty and some pearls and pitfalls of cryoneurolysis. This is an area that's really blowing up, and excited to hear your thoughts on that. Before we dive in, why don't you just tell us a little bit about your background, your training, and your current practice, where you are today?
[Dr. Alexa Levey]
Sounds great. Born and raised in Houston, Texas, but raised by two New Yorkers, so I talk at the speed of light, but I say words like "y'all", and if I'm around Southerners, I might get a little bit of a drawl. I totally did not mean to rhyme them, but that's what happens.
[Dr. Jacob Fleming]
That's what happens.
[Dr. Alexa Levey]
Born and raised in Houston, went to undergraduate at Emory University, came back to Texas for medical school, always knew I wanted to be a doctor. No, actually, that's a lie. Initially, I wanted to be a lawyer, and I pitched that to my magnet school in high school. "Why do you want to go to a math and science program to be a lawyer?" I'm like, "Because the scientific method is really good to use and apply to cases and how you prioritize stuff," and somehow that worked. Obviously, here I am, not a lawyer. I'm a doctor.
I did an internship with my uncle in a hospital, and I just realized that I really wanted to make an impact in people's lives, and so I went to medical school. Medical school was done in Texas because it is so much cheaper if you're a Texas resident, but I did my training at UTESCA in San Antonio, and then ended up back at Emory for my radiology residency, as well as my IR training. I was very lucky at Emory to meet Dr. David Prologo. He is the one who's leading the way with cryoneurolysis and interventional pain. He is so much bigger than anything I think you could ever expect when you meet him. He is an incredibly affable person, amazing with his patients, extremely thoughtful, and really, really wanting to change the world with what he does, and very free with his time and his mentorship. I was lucky enough to be one of his mentees. When I was in residency, did I always think I was going to do pain? No. Did I even think I was going to be a radiologist? No. I initially was going to be a cardiothoracic surgeon, and I think that's a conversation for another time. I'm very happy with where I landed.
My grandmother, when I was in my second-year residency, got diagnosed with metastatic uterine cancer, and she found out because she had pain in her rib. They did everything they could, but ultimately it slowly progressed, and they tried to control her pain with pain medications: oral opioids, over and over and over and over and over again. She had previously had an intrathecal pump because she was in a terrible car accident at the age of 50, and at that time actually was told she'd never walk again. Of course, my grandmother was like, "That ain't happening," and walked again, even though she was in chronic pain. You would never know, but she walked again at that point. She was already on pump therapy, and was already on a lot of high-dose opioids. One time I remember I got a call in the morning from my uncle, who's a radiation oncologist, who was primarily taking care of her, and said, "Your grandmother almost died. They over-medicated her with fentanyl. She stopped breathing. They quickly reversed her. We're doing everything we can to take care of her." Probably the next day I called my grandmother to ask her how she's doing, and I say, "Mimi, how are you doing?" This is my positive, tough-as-nails grandmother who I make cookies with, and unlike me, would never curse, but she said, "Lexi Page, I cannot lie, but I feel like shit, and nobody should ever have to feel this way, ever in their life."
She ended up dying, and that was one of the saddest things to watch such an incredibly strong woman, never complained about anything, raise three rambunctious kids, to sit there and almost be killed by the medicine that's supposed to be helping her, and then die in pain. It became very important to me in my career to try to make an impact on that in any way I can.
I was just fortuitous, as with Dr. Prologo. Took my first job at UT Houston, where I was for the last three years. They had no pain practice whatsoever. Talking of Prologo, you also hear from Dr. Alonzov. The really important thing about collaboration, everybody likes to say, "This is mine. This is my field. I don't want you in it. You can't take my patients." Well, I don't want to do that. You can keep them, but this is what I can do, and this is what I can add that you can't do. How can we collaborate?
I was very lucky that one of my good friends was an anesthesia pain doctor at UT, and she had problems dealing with complex regional pain syndrome. She hated doing stellates, and I would love for somebody to do that. That's how the doors opened with that.
I can get more into how I slowly built my practice, but continued to collaborate, and still do collaborate, with anesthesia pain, with PMNR, with neurology, with vascular surgery, and those patients have a lot of chronic pain, and with orthopedic surgery, how together we can do a multimodal approach to pain.
Very quickly, I would say by the end of my three years, I had patients every single week for pain and was doing probably three to four stellates a week, which if you know how small of a little area that is for stellates alone, that's pretty big. That was towards the end. Then, I decided I needed a little bit of a change. I have a two-year-old who has a lot of opinions, and I have a four-year-old who's the most amazing little man in the world, but he has some special needs, and I'm married to a urologist. Our schedules were pretty crazy. I decided, "Let me try private practice a little bit. Let me try a little bit more of an easy schedule." Easy?
[Dr. Jacob Fleming]
It's all relative.
[Dr. Alexa Levey]
It's all relative. That would maybe allow for a little bit better work-life balance. I ended up going to a private practice, Radiology Partners, where I was told I could build up my pain practice again, as well as anything else I do. Now, I am working on building that again the last three months and have had some success and then building up the Y-90 practice. I have a wealth of information about the transition from academics to private practice and doing cryo in private practice.
(1) Building Cryoablation Practices: Challenges & Strategies
[Dr. Jacob Fleming]
I'm really glad we'll get to talk about that because I think this is a really important topic because cryo, we've seen a lot of advancement with this. Of course, you mentioned Dr. Prologo really leading the charge on that and several other places around the country, but really more centered on the academic centers. I think it's going to be crucial.
Dr. Prologo talked a while back when he was on the show about how he doesn't want people to come to him in a destination-medicine style. He says, "We have this army of interventional radiologists out throughout the country in the community who can do these things." Talking about how we can build up cryo in private practice, maybe since we brought it up, just to say a few words about that. How have you gotten that started in terms of getting the equipment that you need, for example, and the scanner time, and that kind of thing?
[Dr. Alexa Levey]
I'm going to tell you. It's challenging. I've built both practices from scratch, honestly, without a lot of help, just with a lot of grit, a lot of making relationships. It just takes one relationship to get you started. I did the first Y-90 ever at Memorial Hermann Sugar Land. They didn't have it. In three months, I was able to do it, and I'm very proud of that. It's hard. When you go out to a place that doesn't know what you have, you have to give them a reason to support you.
With cryo, number one, they already had access to cryo in general. Normally the rep can just sit there and bring the machine, they can bring the probes, but there has to be a Lawson number, at least as far as Memorial Hermann goes, so that they can adequately bill for it. Then you have to show them, Okay, if I'm going to do this, am I going to use anesthesia? Am I not going to use anesthesia? Is the CT scan able to accommodate anesthesia cases? Does the CT scanner have CT fluoro? Because CT fluoro will cut down on the case time by 25%, and time is money. They can be scanning patients in those times, and those are adequate RBUs. How many probes am I going to be using? Am I going to do more cryoneurolysis versus tumor ablation, which I think those are two completely different things, and actually important to touch on as well. It's a hard thing to grasp that you don't need to do 10-8, 10-8, 10-8 for everything, that you can just do eight minutes and be done. Is there the correct anesthesia hookups? I think I already said that. Are we going to be able to bill for it? Is my private practice group going to be able to bill for the professional fee while the hospital bills for the technical fee? That was something I actually didn't even expect to cross. What is the actual take-home product? is it something that's profitable for the hospital?
I'm actually cringing and feeling knives go in my tummy as I talk about costs in patient care because you don't want to do it. I think it's gross, but it's very important because medicine is still a business. You can help people and still do something that is profitable for the hospital. You need to be able to show them that it is profitable for them to want to support you.
That is a Reader's Digest version of all the things that you need to think about when you're going into it. Now that I've been through it a couple times, it's definitely something that is totally feasible. Don't even mind the insurance and these T-codes. I thought the T-codes were fine and great. T-codes are not good if you're in private practice. There's a lot more work of what you have to do, which is why I'm now even more focused on trying to do research towards this. I just did a paper in JVIR on complex regional pain syndrome and cryoablation of the stellate ganglion, and it was a small group, but at least it's something. There's nothing getting published because it's so hard nowadays to do research as well as the things that people don't realize.
(2) Cryoneurolysis Versus Radiofrequency Ablation in Pain Management
[Dr. Jacob Fleming]
Right. Thank you for sharing all those details. This is not the stuff that we went into medicine to do and get excited about, but it's really crucial to be able to say, "Hey, this is why this thing that I can do and want to do to help my patients is a good thing for you and everyone involved." It's very difficult.
You also mentioned the difference between cryoneurolysis and cryotumor ablation. That is a really great point. I don't want to digress too much into that, but it brought up something that I want to talk about, I think is very important when talking about pain therapies in general. The workhorse of pain ablations has been radiofrequency for decades. You talk to most pain people, they probably haven't used much cryo at all, whereas medial branch rhizotomies, SI rhizotomies, whatever you want to do, it's all pretty much RF-based. As we begin to talk specifically about cryoneurolysis, what are the advantages over RF? Just in general of cryoneurolysis, when and why?
[Dr. Alexa Levey]
Actually I can talk to this because I got a lot of questions about that from the JVIR editor, because they said, "Oh, you can do cryoneurolysis or RF for stellates," and I'm like, "What is RF? The thing that I wrote?" I wrote a book chapter when I was in residency with Darren Kies and Mitchell Ermentrout for treatment of HCCs. I actually wrote about RF and cryo and microwave and why you'd use one, and irreversible electroporation and when you use one versus the other. That was about the extent of my experience with RF because people just are not trained to use it anymore unless you're doing basivertebral nerve ablation, unless you're doing median nerve ablation, like you had mentioned, or you're doing osteocool type ablation in bones. People are not using it anymore.
When we're talking about RF versus cryo and one-on-one, what are the advantages that people say? RF is a lot faster. Okay, great. I will argue that you can do cryoneurolysis, which again, cryoneurolysis, what you're trying to do is cause a Sunderland type 2 nerve injury, which is an injury that basically damages the axon, but leaves all the layers of the nerves intact. By the way, you can't get anything higher than that with cryo because no probes go colder than -100, so very possible. Versus with RFA, you always get a Sunderland 3 or 4, you are destroying the nerve. Because you don't need to spend that long freezing, you can do eight minutes, you can do 10 minutes. It's not going to be an entire 36-minute freeze-thaw cycle, for example. It will be longer, but not as long.
You can see the ice, you can see where it's forming. Remember, ice means zero degrees. Ice does not mean -22, which is actually 22 to 23, which is actually cell death. It just means zero. You can actually see when it's getting close to structures, it may cause inflammation, but won't cause damage. You can't see that with RF whatsoever. It's less predictable.
RF does cause adjacent tissue char when we're doing things in the neck with stellate ganglion. There's the esophagus and the inferior thyroidal artery and the vertebral artery. Again, you have some heat sink and you have the recurrent laryngeal nerve and you have the thyroid and you have the lung right there. It would probably be nice to have something that's a little gentler in the surrounding soft tissue, something that you could see when you're actively freezing. It's a little more predictable.
Something else too, again, talking about the Sunderland injuries, when you're bleeding a tumor or you're ablating a median nerve, those don't carry any motor fibers or anything. You're not really worried about that. Versus with cryo, you're causing a nerve injury, but you allow those to regenerate. Do you really want to do radiofrequency ablation of your splanchnic nerves and destroy them? They're bilateral. Just as God gave you two kidneys, they're probably important and you probably don't want to destroy them. Not saying you can't, but that's the thought process is that you are inducing a nerve injury versus permanent nerve damage, which permanent nerve damage, fine in some settings, not fine in other settings. You're able to see what you're doing versus you can't see what you're doing. It's more general around the surrounding soft tissues. Those are the reasons why I think there's been a lot more of a push for cryo.
[Dr. Jacob Fleming]
Got you. Tell us a little bit about the specific nerve targets you're using it for. Of course, you're doing a lot of work with stellates. What are some of the other ganglia or nerves that you're targeting?
[Dr. Alexa Levey]
If you ever told me I'd be a person becoming what somebody would call an expert in stellates, I would say, “no,” but I do a lot with stellates. I think it all depends on what you're doing, again, talking about nerve targeting, any nerve, honestly. I've done it for phantom limb. I actually published a case report of doing a posterior tibial nerve block and cryo ablation for phantom toe pain after traumatic amputation from atheroembolism. That's something you can do. I've done it for complex regional pain syndrome. I've done stellates for those as well as for VTAC, as well as for long COVID, which is a whole nother topic, as well as for pain control for pancoast tumors. I've done lumbar sympathetics for complex regional pain syndrome. I've done obturator and pudendal nerves, pudendal for pudendal neuralgia, obturator nerves and pudendal for tumoral encasement, superior hypogastric nerves. Those are actually only blocks, no cryos, it's too hard to work around. Those would actually be an ethanol. I've done femoral nerves. Actually, a lot of motor nerves I've done wherever there's tumoral encasement.
Pretty much any nerve you can think of, you can do a cryo of if you can get there safely. The only one I haven't tried yet is I've done a couple of trigeminal nerve blocks and I haven't tried sticking a cryoprobe in somebody's face.
[Dr. Jacob Fleming]
Got you. That's one where the RF technique has been described over the years.
[Dr. Alexa Levey]
Yes, pulsed RF.
[Dr. Jacob Fleming]
You're right. Cryo, potentially could be really great for that, especially, talking about, you mentioned the Sutherland 2 injury, and that it's allowing the nerve to go through that regenerative process. I don't know if this is totally just wrong to think about it this way, but I almost think about it as a neuromodulation sort of thing. We're not just carpet-bombing the crap out of it, but giving it time to reprogram.
[Dr. Alexa Levey]
Exactly. The way Prolovo describes it, and actually I can also back up too and say, obviously I've done celiac, splanchnic, adrenal ganglions, any regulatory center, I've pretty much cryo'd. It's 100% what you're doing, you're basically rebooting the nerve. You're saying, "You are overactive, you are overstimulated. Let me make it so nothing gets transmitted down to you for a while so you can regroup and get your stuff together. You're okay, you're fine, stop sending signals."
[Dr. Jacob Fleming]
Just a digression, is there anything more radiology than saying, "Hey, unplug it and plug it back in again"?
[Dr. Alexa Levey]
No.
[Dr. Jacob Fleming]
IT, radiology, that's our life and training. Hey, it works.
[Dr. Alexa Levey]
On and off. No it totally does. It's great. When it works, it works super well, which is really cool. I really enjoyed it and started getting, I guess, a little creative with it.
(3) Patient Selection & Communication in Cryoablation
[Dr. Jacob Fleming]
There's a lot of room for creativity with it. The interventional radiology mindset is really all about that. I think that's something unique that interventional radiologists can bring to the pain therapies. You're talking about this a moment ago, you can get some raised eyebrows or people getting a little bit defensive of what they consider their turf when we talk about radiologists getting into pain. I think that we come at it from a different angle, and bring some of our problem solving and ways of thinking outside of the box using different tools. Like I said, most interventional pain docs are not using cryo to any significant degree. We've taken that from what's been done within our specialty. I think we can do a lot of really cool stuff with that.
I do want to talk about specifics in terms of, how do you talk to patients about this? Obviously, you just listed off a myriad of different topics or different targets, so many different things, but talk to us a little, in general, about the process of patient selection, how you generally plan your procedures and the discussion in clinic with the patient: what can be expected, talking about risks, and that sort of thing.
[Dr. Alexa Levey]
Sure. That's all these super important topics. Number one, everybody's a candidate. There's always something you could potentially do for someone, and if I can't do it, I know who can. I still have connections with other anesthesiologists, PMNR colleagues, neurology, where I can send the patient somewhere else if there's something that I can't do. Becoming a person who is known for doing pain, if you don't do it all, then you need to know people who can and you need to be able to get them in and be able to network them out because that is your patient. That is the most important thing. You take care of that patient like your mother or your brother, somebody you actually like in your family and treat them like family because there is nothing worse than to be in pain and there's nothing a patient wants more than to be heard and to be understood. Hearing them out and evaluating. There's nothing more than a doctor who wants to. Your patient's in pain and they're terrible, they can't manage it? Let me help you. I will talk to them. If they need something else, I'll discuss it with you and I will get them referred out so they can get their problem fixed. That is the best thing you can do and say to refer and to build your practice. That's the first thing.
My phone is always on for my referrers. All my patients have my email address. I am constantly checking it. If I had a second phone, my patients would have my phone. Being accessible is super important. When I'm evaluating a patient for pain, imagine, is it chronic or is it cancer related? Let's talk about cancer related. I had one that got referred to me over the weekend that I looked at today, a patient who has metastatic cancer of an unknown primary and just has this diffuse nonspecific abdominal pain. Normally what you want to do is read the patient's history, find out if it's acute, if it's chronic, if they have cancer. You want to look at some type of cross-sectional imaging and you want to see first, is there anything on that imaging that looks like it could cause the pain described in the note, some kind of general pain in one area or not? Is there a mass encasing the femoral nerve that's causing pain to shoot down their leg? Do they have a cervical cancer that's invading their obturator or pudendal nerves, something that you could target? Is there something that is in the splanchnic bed that is causing pain, or is there nothing and maybe you just try a splanchnic block to get something general? Look at the notes, number one. Look at cross-sectional imaging, number two, to try to determine some potential targets.
For this particular patient, generalized abdominal pain, it was the most unimpressive CT I've ever seen, retroperitoneal adenopathy, and just diffuse abdominal pain, which she was describing. I looked up a little higher and I realized just inferior to the right where the celiac plexus is coming off at the celiac axis retrocrural is this massive node. Then, I look a little more cranial and there's a lot of dirt in the fat, and I'm like, "Gosh, this node is invading the splanchnic plexus and it's probably contributing to her abdominal pain." What if I planned after I talked to her to treat the splanchnic plexus and then try to treat that little node and cause some regression back from the diaphragm and from the crura and see if that helps a little bit? That's a thought process of things I go through.
Next most importantly, go see the patient, go see the patient yourself. I had people ask me, "This patient has 8 out of 10 pain here. What would you do?" I said, "Where? Can they point to it with one finger? Is it sharp? Is it stabbing? Is it burning? Does it radiate? Does anything make it better? Does anything make it worse? How does it feel when they take pain meds? Does it regress at all? Is there anything that exacerbates it?" You really have to get incredibly granular with pain patients because what you'll find is often you will help pretty much every single patient but not to the degree that they would normally think about it, if that makes sense. You can make a change and impact everybody's pain, who you treat, but it will be in one certain sector of what they categorize as their pain. They'll get less crampy. They'll be able to eat more. They'll still get a crescendo of their pain, but it will be to a five or six versus a 9 out of 10, and it will go away faster. The more granular you can be with your patient interview, the better you will be at helping your patients succeed in getting their pain under control and realize that they are making progress.
That also being said, the first thing I say to patients when I see them, and it's the hardest thing to say to somebody is, "I'm sorry, but there's no way I'm going to be able to make your pain zero. That's not possible. If anybody tells you that, they're lying to you. That's a hard truth to accept that you're always going to have some level of pain, but I am here to help you manage it. I am here to help you get through it. I am here to hopefully reduce it by 50%, if not more. I am here to hopefully get you on a lower dose of opioids so that you can be more active in your life, you can get out, you can drive, you're not sleeping all day, you don't feel constipated, and you don't feel nauseous. If that doesn't work, here's plan B." I think having a very honest and real conversation with the patient is the most important thing. There are no magic wands for pain. It is always going to be multimodal in management. A big part of what I do is therapy, 100%. I would say that my initial clinic visits are usually about 35 to 40 minutes and the follow-ups are much faster. That's actually for any patient I see. That's just the way I am. I like to describe things, everything, and be very thorough so that if anything comes up, they can feel free to ask me. My subsequent visits actually end up being a lot shorter.
With pain too, when you do that, you can actually help patients identify what kind of pain they're having, get those granular things, and then you have something to compare to. Then, you could show them their progress. I can say my complex regional pain syndrome patients I've treated, they actually continued to improve. I think that's just because of learning to accept that this is their new baseline and their new normal, not because I didn't do anything, I usually get them a decent amount of pain relief, but them willing to adapt, being able to do more physical therapy, and learning to do some cognitive restructuring about what their current life is. That's so important. That's how you maintain a practice. That's why I can say I love my pain patients. They're amazing. People are like, "Are you crazy? They're so hard." It's like, no, they just want to be heard. They need little goals, little things to say, "Look, this is what you said before. This is what's happening. That's good. Not to say that your current pain is not important, but look where we have made strides and made improvements."
Those are things I really focus on in the clinic visit. Of course, I talked about that in my physical exam, asking about history, blood thinners, typical procedural things, chronic health issues, and then I plan for a procedure if I have something to target. Usually I have multiple steps after that.
General risk with cryo, gosh, it depends. Is it going to be close to the skin and they can get frostbite? Depending on the pathophysiology of the disease, when I cryo a stellate ganglion for VTAC and for complex regional pain syndrome, they do great. Some get Horner's. When I do it for long COVID, a third of them get Horner's and they get a raging neuritis, which some describe as the worst pain in their life, which goes away after six weeks, very predictably. You have to talk to people about that and tell them how to manage it and guide them through it, have follow-up visits, tramadol for pain, lidoderm patches for the shooting neuritis, anti-inflammatories, bedroll dose pack. You have to be able to handle all those things.
Also, it brings up another really big important point. You should almost, I say almost never because there are situations I do, go straight to cryo. You do a block first. You need to make sure people have success with the block so that they can want to have longer lasting relief and see that it's actually efficacious. Especially, I have people coming to me and asking me questions now about just doing cryo for long COVID. Don't do that. Not a good idea to go straight there. Because of the side effects of having the cryo in that particular pathophysiology, you're not going to have any more patients after your first one.
[Dr. Jacob Fleming]
Really good point there. That was something you mentioned to me earlier I hadn't really thought of before, about the different response between blocks and cryo. Can you expound on that a little bit more? What are the situations in which you see quite a different response?
[Dr. Alexa Levey]
I would say in general, talking about response to treatment. If you have a positive block, you're going to get a positive response to cryo and it will be about the same level, if not a little bit more. It's usually very predictive of how they're going to do.
Now, when we start to change the pathophysiology of what we're doing, remember cryo too, you can't distinguish sensory and motor. For example, if I'm going after a tumor encasing the obturator nerve, I already know that's going to affect adduction, but older lady, she has a walker and within about six months, it's going to regenerate. She's going to be fine. She can still walk without her adductors and that's okay. All those things are what are going through my mind whenever I'm thinking cryo.
Whenever I'm talking about, block versus, again, cryo, sorry, I'm being a little repetitive. Blocks are temporary. You inhibit signaling via two different methods with a local anesthetic and then also with a steroid. There's two different mechanisms by which those actually inhibit neuronal-signaling and can actually regulate pain and nociceptive signaling. Obviously over time that wears off, and the whole idea with cryo is that it lasts a lot longer. I would always do a block before cryo, except in those cases when I have patients who have tumor encasement and I can target it to a nerve, then I'm not necessarily going to always want to put a bunch of steroids around a nerve. I'd probably just go ahead and cryo that area. After we have a nice thorough talk about the consequences of cryo-ing certain nerves.
I did have one patient who was in her 30s who had metastatic cervical cancer and had been in a wheelchair for the last three months and unable to walk, and terrible pain in her legs. I was able to map it out to, I'm already forgetting which nerve it was, but I said, "Okay, I see this, I can map out. This is where your pain is. I see tumor encasement. I can ablate this and I can get you pain relief and numbness and tingling, but you're not going to be able to walk with this leg." "Oh, that's fine. That's fine." So I said, "No, you don't understand. You're going to feel better and you're not going to be able to walk. Are you going to be okay? Within about six months, you can do braces and boots and stuff and the nerve will regenerate unless the tumor grows back and invades it again.” I will say I have had patients who had two years out for the tumor to regrow and cause issues. This is something that's really good and really efficacious for patients. Of course on board. "Yes, doc. Yes, doc." I made sure to record this and have plenty of conversations. Next day, I went and saw her after I ablated her. In tears. "I can't walk. I can't walk. I can't walk." I said, "How's your pain?" "It's gone." Okay. For those things too, I would say, in general, you can go straight to cryo, but just make sure you have a very, very, very real talk with your patients and make sure you document about what's going to happen too.
[Dr. Jacob Fleming]
Absolutely. The expectations are so important. My mentor, Dr. Beal has said, "The patient needs to be able to be a partner in their own care.” I think we can't make all our patients want to cooperate and that kind of thing. I think explaining as best as we can and trying to get on their level of understanding and really letting them know, "Hey-", you said earlier, "-I'm not going to be able to take your pain away 100%. We're going to do our best to mitigate it, and then these are potential things that can happen.” Just letting them know. A lot of times it, when you're going for a mixed nerve and predictably you get a motor deficit afterwards, if the patient knows what to expect, a lot of times they may say, "Hey, I knew to expect this." Other times patients say, "Yes, let's do it," and maybe they're not hearing it to the same extent that you want to, but it's so crucial to have that conversation. Obviously on the medical legal aspect, it's completely indefensible if the patient had no idea, "Hey, I'm not going to be able to walk after this." That's no good.
[Dr. Alexa Levey]
Correct. Then also too, even if it's just a sensory thing, they can have some numbness and tingling, making sure they have that. If you do an ablation for pudendal neuralgia, they're going to have some numbness down there and not have some sensation down there. You have to make yourself very clear about that. Genitofemoral nerve blocks, I do a lot for chronic testicular pain. Haven't gone after ablating those yet because I don't think that's going to be very well tolerated by the patient. Making sure you have, as you said, very very clear expectations and that they are a part of their care.
(4) Stellate Ganglion: Functions, Treatments, & Innovations in Pain Management
[Dr. Jacob Fleming]
Absolutely. We've been teasing it for the whole time so far. I would like to jump in and talk some specifics about the stellate ganglion. First of all, what the hell is the stellate ganglion?
[Dr. Alexa Levey]
I love it. The way I describe it to my patients in Houston, and you think about it in any big city you are, think of it as it's the 610 loop in Houston, it's the big loop that goes around the city. It sits on either side of your neck and it receives inputs coming in from the brain, go into it, get regulated, go out to the extremities, go down your chest, go down to your heart, go to the tops of the lungs, and then vice versa. Things come back in there and get regulated. It's a major regulatory center of inputs from the brain and from the extremities and vice versa.
It has been implicated as far back as the 1940s in playing a role in heart regulation. What they found is that people who have rapid heart rates, if they did a sympathectomy of the left stellate ganglion, refractory ventricular tachycardia, some patients would get some improvement in those symptoms. Over time, they started blocking the stellate ganglion. They would block the left and then if that didn't work, they would try blocking the right. Never at the same time because the thought is that you could potentially completely stop the heart. With that being said, I can tell you I have now cryo-ablated both sides, granted that patient, now ears wide open, had a pacemaker and was a hundred percent pacemaker-dependent. I wouldn't just jump in and do that.
That's where it first started off in the literature was refractory ventricular tachycardia. Then what they found out, and I forget why this was initially done, is they did a lot of retrospective studies on combat veterans and they found that combat veterans, when they blocked the right stellate ganglion, they had better outcomes with management of their PTSD and anxiety when in combination with therapy than without the stellate ganglion block for up to or over three months. Usually three months was when they start seeing a lack of benefit and they'd usually have to go back in for another block again. That was using only lidocaine. Very interesting, not always using a steroid versus if you look at retractory, whenever you have VTAC, if you do lidocaine, as soon as that's off, they're going right back into VTAC. If you do a steroid, once that wears off, they're going right back into VTAC. There's also some interesting nuance, I would say, too, to VTAC to which patients respond and which don't, but I think I'll avoid diving deep into that right now. You can do an assessment and determine who's going to respond. Just interesting to know, PTSD, lidocaine kind of works, VTAC, good. Complex regional pain syndrome, so regulatory of nociceptive symptoms, particularly for the upper extremity and for the face, is the target of the stellate ganglion. Again, once the block wears off, symptoms come back.
Then we get into long COVID. There was a paper published that looked at two case reports on patients where they blocked the stellate. Why would they block the stellate for long COVID? That makes no sense. Long COVID is not just a, "I'm a little sick," cough that people seem to think it is. It is this terrible syndrome where patients have a predominant of dysautonomia symptoms where their heart rates can be anywhere, resting, 120 to 130, they stand up, it's 140s, where they have these terrible vertigo episodes daily that they feel like they're going to pass out multiple times a day. I had a patient who got a subarachnoid hemorrhage as a result of this dysautonomia, where they develop POTS syndrome and their blood pressure drops into the toilet, but then goes super high and patients have underlying hypertension. They're on all these weird antihypertensives and then their blood pressure drops, they get dizzy and they faint, where they have terrible brain fog, where they try to sit there and think about what words they want. It's almost like they've had a stroke. The words are in their head, but they can't communicate them out, where they have problems with anterograde memory, where they have problems with multitasking, where they can't multitask anymore, and they can't focus, worsening anxiety or PTSD. I had a patient whose anxiety got so bad that she was literally like a board in the room and couldn't move. It was debilitating to anything that she could do. These patients, these are nurses, people that work at the grocery store. I've had doctors and people who can't work or function in society anymore. Then there's the pulmonary stuff.
This is long COVID. This is something that I have become really passionate about ever since I started seeing some of these patients. With the history of the regulation of the stellate ganglion on the heart and in PTSD, somebody said, "Huh, let me see if this helps with long COVID." That case report showed that it did. The patient had a dramatic improvement in their symptoms. With what? With lidocaine. I don't want to get too much into it because I do have a paper that's submitted on a study on several patients that we did try to keep it very pure lidocaine only so that if this is something that does get published and, hopefully, that's what insurance companies need because let me tell you, private factors or anything to do with pain or with nerves, insurance companies, wow, they don't want to help you. They don't want to help the patients.
[Dr. Jacob Fleming]
No, they do not.
[Dr. Alexa Levey]
It's all considered experimental. If pain is also something you want to get into, get ready to do peer-to-peers. I will tell you, I have fought tooth and nail for a lot of my patients, and particularly, my long COVID patients. I am so happy every day that I did. Get ready for it because until you do more research, this is what's going to happen.
[Dr. Jacob Fleming]
Absolutely.
[Dr. Alexa Levey]
Anyways, stellates for that. Then eventually cryos for some, when some of them have blocks wear off. Some of them, I have one patient who's a year and two months out, his block is still working.
[Dr. Jacob Fleming]
Wow. It's really unpredictable. That's one thing about pain is even with something as simple as a knee injection or a hip injection, we can typically tell them, "Hey, you will get some relief from this, but for how long, I don't know." It's hard to say because clearly the benefit for some patients way outlasts the duration of the medication. There's certainly things that are much deeper to that. We talked about neuromodulation. Obviously, a block is not really neuromodulation, but there's something deeper there. We always have to be able to talk to the patients about not really sure how long it will last, but if it does come back, here's what we can do in terms of cryo and those kinds of things. I'm really interested about how multi, just multi-use, the stellate ganglion is. It does so many different things.
[Dr. Alexa Levey]
It's incredible.
[Dr. Jacob Fleming]
It's really amazing.
[Dr. Alexa Levey]
At one point, my partner, Dr. Zvavanjanja, who's amazing, he's one of my colleagues at UT, was like, "Levey, I looked at your schedule and it was stellate, stellate, stellate, stellate, stellate, stellate." Honestly, even if you're getting into pain, it's something that really opens a lot of doors because all medical ICUs have patients that go into refractory heart centers. Heart and vascular centers have people that go into refractory VTAC, and they are desperate. They've had multiple ablations, other things. If you're the person who can come in and do a stellate and then subsequently a cryo, you are really making a really, really big difference and adding a pillar to something that can help people.
That's what we're doing as interventional radiologists and just in general. I'm at the tumor ward today, and it was so cool as we're talking about all those recurrent sarcoma. "Oh, we can maybe do this, can we resect it, but it's such a mess." "Oh, I can do some targeted radiosurgery." I was like, "Oh, I could probably cryo that and it would be fine." Then we're talking about different treatments for things and how multimodal we have been able to do it. Now, patients, it's not, "This is the last choice." It's like, "This is one of many choices of things that you can do." That's the cool thing about what we do.
(5) Mitigating Risks in Stellate Ganglion Interventions
[Dr. Jacob Fleming]
Yes, it is really cool. Just bringing everything in the toolbox to the problem at hand. One thing I want to ask is with the stellate ganglion being so important for so much regulation, what are the potential complications of blocking or ablating it? Are there any serious untoward consequences that you talk to the patients about as a result of this?
[Dr. Alexa Levey]
In general, it has to do with targeting. Before the advent of using ultrasound, which some pain physicians still don't, they use fluoro, complication rate was as high as 20% that something could happen. Because let's talk about the eloquent anatomy that is there, the vertebral artery, the carotid artery, the jugular vein, the inferior thyroidal artery. The lung is right there on top because I tend to aim for T, the anterior aspect of the origin of T1 versus anesthesiologists aim for T6. Guess what? Recurrent laryngeal nerve is there. The thyroid is there. You're a lot closer to the aspect of the esophagus. All these things, bleeds, strokes, hoarseness, pneumos, all that stuff, a lot of the complications can be significantly decreased just by using ultrasound. Using ultrasound allows you to mark your position. You can use lidocaine to hide or to set, to push things away. Actually, my favorite combination is using CT with ultrasound. You do a CTA, you map everything out, you draw a line where you want to stick, you place your probe on that line, and then you stick your needle in there. It takes two minutes, and it's fantastic and very quick. The results are usually immediate.
Also important to note with blocks, results are either immediate from the bupivacaine, or they slowly increase over the next 24 to 48 hours and peak at 72 and stay maintained once the steroid kicks in. Versus cryo, immediate. All those things caused by those complications are things I still talk to patients about. In reality, is it something that I wish I could find wood to knock on? I have nothing. I have my Peloton box, by the way. When we talked to Dr. Saad about what he has, he has his thing on kypho boxes. I have my thing on a Peloton box because you can't preach health if you're not a part of it.
[Dr. Jacob Fleming]
Yes. You're actually riding the Peloton right now as we speak, aren't you?
[Dr. Alexa Levey]
100%. Doing an Olivia workout. She's nuts. I forgot what we were just talking about.
[Dr. Jacob Fleming]
You actually got into the next question I was going to ask, which is the actual procedure of either blocking or ablating the stellate ganglion, which is great.
[Dr. Alexa Levey]
I still talk about all those complications, but I say they're at less than 2% risk. All the ones I've done, I probably had one retropharyngeal hematoma from a cryo, and that's it. The whole thing too is when you do a block, you use a 17-gauge needle. When you do a block, oh my gosh, we stick a 22-gauge needle in everything. Actually, when I tell patients, I was like, "Here, you see my PA right there? I could take the needle, poke her in the belly with it, poke her aorta about 10 times and say, 'Have a great day.'" She'd be a little upset at me because she's going to be sore, but ain't nothing going to happen. The safety profile of the needle we use, we do that for subarachnoid gastric nerve blocks and all that stuff. It's so safe. Is there any person that I wouldn't do a stellate on? No. I think it's probably one of the more safe procedures versus splanchnics. You're scanning by lungs and you're right there by the diaphragm and by the intercostal nerves and getting the right angles. You can actually cause a lot more harm, but a stellate?
[Dr. Jacob Fleming]
Got you. You mentioned Horner's earlier. Is that something that shows up in the context of these?
[Dr. Alexa Levey]
Yes. Usually, it's expected. It's actually funny. It's a lot more reported in the anesthesiology literature. I wonder if it has to do with getting a lot closer to the superior cervical ganglion because they're hitting it at C6 versus I'm hitting it at T1 because I would say rarely does it happen. Again, with my long COVID patients, about a third of them. Always something to talk about. When it comes up, it usually goes away after about a week.
[Dr. Jacob Fleming]
Got you.
[Dr. Alexa Levey]
It's almost a positive finding. They actually used to say when you're doing stellate ganglion blocks, and now I also can tell you it happens with cryos too, is the positive findings that you hit it. Horner's syndrome, unilateral, bilateral, or contralateral, don't specify, an increase in temperature on the ipsilateral side and a feeling of that increased temperature on the ipsilateral side are all positive findings that you actually hit it.
[Dr. Jacob Fleming]
Got you. That's really interesting because we think of those as being complications, things we don't really intend, but they are positive findings. These are expected outcomes really. That is really good to know. That's something that's good for the patient to know upfront.
[Dr. Alexa Levey]
Yes. You may look like you have a stroke, but you didn't. Actually, it's very important to warn the patient it's not a stroke. Now, if other things start happening, maybe go to the hospital.
(6) Cryoprobe Selection for Effective Stellate Ganglion Procedures
[Dr. Jacob Fleming]
That's great. We talked about the entire approach for the stellate ganglion block and cryoablation. I'm a little bit of just an equipment nerd. I'm just curious, tell me about the cryoprobes you use. For most of these cryoneurolysis cases, are you just using one probe? These aren't really the tumor ablations that Dr. Jennings or Dr. Saad do with a jillion probes placed in.
[Dr. Alexa Levey]
100%. Very important. Also important too, when we're talking about focal tumoral metastasectomy, when it's encasing a nerve and you do a one-to-one match, even then, I go gangbusters-ish, but I'm not trying to get rid of the whole met. That's not the purpose. This is for pain and palliation. I'm making sure I'm targeting everything around the nerve, but I wouldn't use more than three or four probes and probably ice horses around that area. When we're talking nerve ganglia or any nerve to ablate, well, where are you ablating? What type of shape do you need? If you're ablating along the vertebral bodies, then you want more of a rod-type shape, so you cover the whole area. With splanchnics, they sit from T10 to T12 retrocrural. You have a larger area to cover and it's oval in shape. You want to use those. Pearls may not get as much coverage back there. Force, way too big.
Again, keep in mind, we're just injuring the nerves. We're not trying to create a massive ice ball that people love to sit and tweet and show. Whenever we're doing stellates, again, I'm resting the probe on it. Whatever is anterior to the probe is what I'm going to freeze. I would say you probably could use almost anything. I use a seed, actually an ice spear, not a seed. You could probably use an ice seed. I don't like ice seeds very much because they tend to freeze along the shaft upwards and backwards. It increases the frostbite. If you use a spear, single eight-minute, that's all you need. When we're talking about sympathetic ganglion, 10-3-3-3 is something you do. Although today I did 10-3-5-5, just because it was a little bit more fat behind the crura. I wanted to make sure I got really good coverage. It's a little bit of a gestalt and a little bit from talking to other people. Dr. David Prologo obviously has been a really big mentor of mine and helped me out with that. Then, I would say the workhorses are probably the spheres and the rods and then the forces whenever you have tumors, cryoneurolysis tumors.
(7) Pearls & Pitfalls in Stellate Ganglion Neurolysis
[Dr. Jacob Fleming]
So much great information there. Do you have any other pearls or pitfalls you want to share specifically about the stellates and then just in general about neurolysis?
[Dr. Alexa Levey]
Know your pathophysiology. As I said, I'm learning how patients respond to blocks with and without steroids differently based on the pathophysiology of the disease. When you're blocking the exact same area, when you cryo the exact same area, nothing happens. Some patients suffer pain relief or they get complete symptomatically, but they get a raging neuritis. Understanding the different disease processes have different effects on the nerves you're treating is very, very important to know.
Having a good relationship with patients is so important, being open to communicating with them, constant communication. Hearing them when they say, "I still have this pain," is really important. You really have to hear your patients. It's very important. Being able to collaborate with others, playing in the sandbox, is crucial to building a practice. Then, if you're in the private practice realm or even in academics, being able to talk the talk about finances and when things are beneficial, being able to talk to them about, just like with kyphos, you can decrease patient stay in hospitals by doing a kyphoplasty and increase your pain relief without opioids by doing a kyphoplasty versus having them sit there. Same thing with these pain procedures. You can help turn things around and get them out of hospitals faster. For hospitals, be like,I could do a block as an inpatient, then bring them back for the cryo. All these things you can do with practice building. Colleagues, oh my gosh. I've texted so many people about different things and vice versa. Learning what your network is and learning how to build it is very important. Knowing you can reach out, you have a whole community of people you can reach out and ask, and I'm just a tweet away if anybody has any questions.
[Dr. Jacob Fleming]
Fantastic. Thank you. I really like what you said earlier about how available you are to your patients and your reference. Reminds me of one of our guests, Wayne Olin, said on a recent appearance, availability is the best kind of ability. We talk about the three As, being affable, available, and able. I think it's so crucial. I'm obviously really interested in this area. I'm frustrated sometimes that I get pushback from people within our own specialty saying, "Oh, well, X, Y, Z, specialist or whomever isn't going to let you do that." My experience has been that that is just not accurate. It's not accurate. As long as you're collegial and build up those relationships with them and show how you can help them, they are going to love you for it. Especially if you're available, if they have a question and can call you up and say, "Hey, is there anything you can do?" As an interventional radiologist, the answer is rarely going to be, "No, I can't do anything." It's like, "Hey, well, we can try this."
[Dr. Alexa Levey]
100%. Actually, your answer should be, "Shoot me the MRN. Let me look at it. If you ever have any question about anything, anybody's in any pain or anything, just shoot it to me and I'll look at it." That goes with anything with radiology. Robert Ryu wrote this very good posting online about "trash IR" that people call, ports and paras and thoras and stuff. Those are some of my actual favorite procedures because they're very personal to the patients. Those are patients that you have returned to you. You're actually doing something to help immediately relieve pain when it comes to paras. It's very personal to them. There is no such thing. There is no small procedure. There's no small referral.
You want to do these things that people think are so cool. It always starts with the small stuff, and it starts at the level of the patient and the patient care. You show a patient good care and that you're there for them and that you listen to them, then that will return times 100. They'll tell the referring doctor how much Dr. Levey cared about them. Dr. Levey does the best para because she uses a lot of lidocaine and plays music. The biggest compliment, I think I'll end on this, being involved in pain is everything I do for a patient I want to be less pain. I had one patient at a kidney biopsy and said, "That's it? God, I felt like I was at the spa."
(8) Future Directions for Cryoneurolysis: From Innovation to Mainstream Adoption
[Dr. Jacob Fleming]
Wow, that's quite the compliment because I've been involved in some kidney biopsies that I would not put anywhere in the same realm as a spa visit. That's quite the compliment. My next question that I had written here as I'm looking at them, wow, this is really pretty unhelpfully vague is just future applications of cryo. We've talked about current applications of cryo and it almost seems science fiction.
I'm going to narrow that a little bit and just say, what are you excited to see happen with cryoneurolysis in the next couple of years in terms of maybe things being more widely adopted or trying out new targets? What's on your mind that you're really wanting to get into next?
[Dr. Alexa Levey]
Honestly, it's going to be having it be more widely adopted. For that, we need those codes. We need full-fledged codes. For that, we need research. That's something I know that I am personally trying to work on. It's so hard. There are so many barriers to doing good research right now, and you need a lot of support in order to do it. That's really going to be the key to getting and pushing things forward and making them become more mainstream and more acceptable and then more accessible to patients. I think that starting off with anything you can do retrospectively to just show and start to beef up the literature is really going to help it take off. I think that there's a lot of research to be done.
Actually, what I'm excited about, it took me three years at UT to beat into the like, "Oh my gosh, why are you resecting desmoids? We should cryo these. We should do TK inhibitors. We can do embolizations." Finally, something that's on the forefront. An oncologist I work with came up with a protocol where you can discuss TK inhibitor, and then after TK inhibitor, do you consider cryo or do you consider embolization? There's this really cool desmoid tumor of the foot I saw. I was like, "Gosh." It was previously resected and irradiated. I'm like, "Oh, well, if I cryo that, I'm going to destroy all those tendons and everything else, but I can try embolization. I can do embolization with doxorubicin, which is local, and then we'll go to the lung." Those are really responsive to doxorubicin, something else cool you can do. All these things we can do and get into this world of, say, for example, I guess something would be cool, more so see it more of a standard of care treatment in some desmoids in certain desmoid tumor treatments. I think I would like to see that start to pop up in the NCCN guidelines, especially since resectioning locally recur a lot.
I think that that is some things that are on the forefront right now that we're going to start seeing more of cryo, the treatment of desmoid tumors, cryoneurolysis, I think becoming more of a standard of care with cancer patients, especially once we start coming up with more data. Celiac blocks are already something that are looked at there, so I'm very excited to see that. I think those are probably the main things, but I think really it's going to take a lot more research, a lot more talking, and a lot more acceptance from people. It's going to take our colleagues helping to push for it to help get it more mainstream.
[Dr. Jacob Fleming]
It's definitely a team effort. I think the more that we can get the knowledge out there about what's even possible, and I have learned so much just being able to talk to you tonight about what is possible using this. This is something that I'm really into. Talking to some of this stuff, even to some of my colleagues who are physicians, they're like, "What?" It's like science fiction. IR has been that way for a long time. Now, some of the things that we have pioneered that used to be unthinkable are now common, done every day, and to the point that other specialties steal it. That's a little joke.
[Dr. Alexa Levey]
Or, we teach them, which is our own problem too, which we shouldn't be.
[Dr. Jacob Fleming]
Exactly. That's just a little joke. We're all about collaboration, right? We're all about collaboration.
[Dr. Alexa Levey]
Yes, but I will say people used to drill holes in people's heads to relieve pressure. Then, intrathecal cocaine was a real thing. The good old days, but all these things came from somewhere and you have to try and you have to see what it works. I think once, especially if you show people that you're collaborative and stuff, they'll be willing to let you try and let you work with them. Then slowly, things start becoming more mainstream and more accepted. Then things start coming out. Really, I think it does take, as I keep hammering on that collaborative nature for all this stuff to get published and become what is the new standard of care. I think cryo is well on the way for that, for pain management, as well as for treatment of certain syndromes.
[Dr. Jacob Fleming]
Yes. I don't think I could have said it any better. That was really well said. I don't have anything else to add or ask. You have just answered, just knocked all my questions out. I think that is a fantastic place to end. Any final words you'd like to share with our listeners?
[Dr. Alexa Levey]
Anything is possible. Even if you don't feel like you have the support, you can do it. It's challenging, I would say, being a female in a male-dominated field. I'm incredibly honored. I don't know how many women you've had on your podcast, but I'm incredibly honored to be a female on this.
[Dr. Jacob Fleming]
Thank you so much for joining us. It really means a lot.
[Dr. Alexa Levey]
It means a lot. To let people know that you can do it, you do have support. You could have a two and a four-year-old running around being crazy, but with the support of your friends and colleagues, anything is possible. Just always do what's best for the patient and fight for the patient and everything will work out.
[Dr. Jacob Fleming]
That was beautiful. I can't think of a higher note to go out on than that. Thank you so much. Before we end, what's your Twitter or X handle for our listeners to follow you?
[Dr. Alexa Levey]
It's super complicated, @alexalevey, with an extra E, L-E-V-E-Y.
[Dr. Jacob Fleming]
That's pretty complex. We'll add that to the show notes just in case they missed it. Dr. Levey, this was fantastic. Like I said, I've learned so much. I can't wait for our listeners to hear about this. As you said just a moment ago, I really want to see how this expands in the next few years and we bring this out and this becomes more of a mainstream therapy. Really excited about all the things we talked about. Again, thank you so much for your time coming on the show.
Podcast Contributors
Dr. Alexa Levey
Dr. Alexa Levey is an interventional radiologist, interventional pain proceduralist, and assistant clinical professor in Houston, Texas.
Dr. Jacob Fleming
Dr. Jacob Fleming is a diagnostic radiology resident and future MSK interventional radiologist in Dallas, Texas.
Cite This Podcast
BackTable, LLC (Producer). (2023, December 18). Ep. 37 – Cryoneurolysis Pearls & Pitfalls [Audio podcast]. Retrieved from https://www.backtable.com
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.